Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.

Endokrynologia Polska - 1 Jan 2000

Pisarek Hanna, Pawlikowski Marek, Kunert-Radek Jolanta, Radek Maciej

Abstract excerpt

BACKGROUND: The highly variable expression of SSTR subtypes in pituitary adenomas (PA) may partially explain why the subgroup of somatotropinomas or other adenomas do not respond to the therapeutic action of currently used long-acting somatostatin analogues like octreotide or lanreotide. MATERIAL AND METHODS: Our study summarizes the data on expression of all somatostatin receptor subtypes (SSTR 1-5), extended...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma
Share to Antineoplastic Agents, Hormonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Peptides, Cyclic

Share to Pituitary Neoplasms

Share to Protein Isoforms

Share to Receptors, Somatostatin

Share to Somatostatin

Source

Identifiers

PMID: 19753537

Genes

SST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.PMID 19753537Read ↗

Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.Semantic proximity Read ↗

Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.Semantic proximity Read ↗

A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.Semantic proximity Read ↗

The 2017 WHO classification of pituitary adenoma: overview and comments.Semantic proximity Read ↗

Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations.Semantic proximity Read ↗

Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profilesSemantic proximity Read ↗

Genetic abnormalities of somatostatin receptors in pituitary tumors.Semantic proximity Read ↗

Truncated somatostatin receptors as new players in somatostatin–cortistatin pathophysiologySemantic proximity Read ↗

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.Semantic proximity Read ↗

Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST 5 ) in pituitary and pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumorsSemantic proximity Read ↗

Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.